| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/07/2001 | EP1081138A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081131A1 Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions |
| 03/07/2001 | EP1080722A1 Antimycotic compositions |
| 03/07/2001 | EP1080721A2 Non-crystalline solid dispersant comprising cefuromixe axetil |
| 03/07/2001 | EP1080371A1 Method and means for caries prevention and susceptibility detection |
| 03/07/2001 | EP1080370A1 Identification of broadly reactive dr restricted epitopes |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080198A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080184A1 Method for activating natural killer (nk) cells |
| 03/07/2001 | EP1080181A1 clpX OF STREPTOCOCCUS PNEUMONIAE |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080109A1 Method for purification of borrelia lipoprotein ospa |
| 03/07/2001 | EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/07/2001 | EP1080094A1 G-csf mimetics |
| 03/07/2001 | EP1080093A1 G-csf mimetics |
| 03/07/2001 | EP1080091A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| 03/07/2001 | EP1080086A1 Dihydropyrimidines |
| 03/07/2001 | EP1080079A1 Thermally stable trimetrexates and processes for producing the same |
| 03/07/2001 | EP1080078A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 03/07/2001 | EP1079858A2 Oral immunization with papillomavirus virus-like particles |
| 03/07/2001 | EP1079857A1 Combination meningitidis b/c vaccines |
| 03/07/2001 | EP1079856A1 Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 03/07/2001 | EP1079855A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA) |
| 03/07/2001 | EP1079846A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 03/07/2001 | EP1079839A1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
| 03/07/2001 | EP1079831A1 Compositions for the treatment of hiv and other viral infections |
| 03/07/2001 | EP1079826A2 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| 03/07/2001 | EP1079819A1 Hydroxamic acid derivatives as antibacterials |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079809A1 Enteric coated pharmaceutical composition and method of manufacturing |
| 03/07/2001 | EP1079808A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/07/2001 | EP1079807A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
| 03/07/2001 | EP1079806A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/07/2001 | EP1079802A2 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/07/2001 | EP1079790A2 Broad spectrum microbicidal and spermicidal compositions, devices, and methods |
| 03/07/2001 | EP0736015B1 Antiviral 2,4-pyrimidindione derivatives and processes for the preparation thereof |
| 03/07/2001 | EP0730597B1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 03/07/2001 | EP0730579B1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 03/07/2001 | EP0641325B1 Retroviral protease inhibitors |
| 03/07/2001 | CN1286727A Neisserial antigens |
| 03/07/2001 | CN1286696A Liposomes comprising peptide antigens derived from X protein of hepatitis B virus |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/07/2001 | CN1286252A Process for preparing epigallocatechin gallate |
| 03/07/2001 | CN1286120A Cholera vaccine prepared from transgenic carrot and its preparing process |
| 03/07/2001 | CN1286117A Medicinal composition for treating pelvic inflammation |
| 03/07/2001 | CN1286109A Exterior-applied medicine for treating beriberi |
| 03/07/2001 | CN1286103A Medicine for treating AIDS |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062867C Derivs. of 12,13-epoxy-tylosin and processes for mfg. thereof |
| 03/07/2001 | CN1062860C Triazine contg. anionic compounds useful as antiviral agents |
| 03/07/2001 | CN1062858C Phenyl-substd alkenylcarboguanidides carrying perfluoroalkyl groups, process for their preparation, their use as medicament and medicines |
| 03/07/2001 | CN1062770C Vaccine both for hepatitis A and measles, and production method therefor |
| 03/07/2001 | CN1062739C Medicine for preventing sexual disease |
| 03/07/2001 | CN1062737C Medicament for preventing and treating several fish diseases |
| 03/07/2001 | CN1062736C External use emulsion for treating burn |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197955 Production of staurosporine derivative using acid isomerization |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197793 Hemoregulatory compounds |
| 03/06/2001 | US6197757 Particles, especially microparticles or nanoparticles, of crosslinked monosaccharides and oligosaccharides, processes for their preparation and cosmetic, pharmaceutical or food compositions in which they are present |
| 03/06/2001 | US6197755 Compositions and methods for delivery of genetic material |
| 03/06/2001 | US6197583 Therapeutic compounds |
| 03/06/2001 | US6197582 Development of human monoclonal antibodies and uses thereof |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197496 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80 |
| 03/06/2001 | US6197344 Butorphanol sustained release formulations |
| 03/06/2001 | US6197312 Surface antigen |
| 03/06/2001 | US6197310 Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits |
| 03/06/2001 | US6197300 ftsZ |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA2021379C Pentapeptide antibiotics derived from dalbaheptides |
| 03/06/2001 | CA1341201C Bis-(hydroxymethyl) cyclobutyl purines and pyrimidines |
| 03/01/2001 | WO2001014584A2 Methods of identifying anti-viral agents |
| 03/01/2001 | WO2001014576A2 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014416A2 Synthetic papillomavirus genes optimized for expression in human cells |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine |
| 03/01/2001 | WO2001014401A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 03/01/2001 | WO2001014399A1 Novel a-500359 derivatives |
| 03/01/2001 | WO2001014397A1 9a-azalides with antibacterial activity |
| 03/01/2001 | WO2001014393A2 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 03/01/2001 | WO2001014387A1 28-epirapalogs |
| 03/01/2001 | WO2001014364A1 Fatty acid synthase inhibitors |
| 03/01/2001 | WO2001014363A1 Fatty acid synthase inhibitors |
| 03/01/2001 | WO2001014362A1 Fatty acid synthase inhibitors |
| 03/01/2001 | WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 03/01/2001 | WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 03/01/2001 | WO2001014343A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |